SEREVENT DISKUS is a Oral; Respiratory (inhalation) Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Salmeterol Xinafoate.
Product ID | 68258-8961_198f20a2-218e-4a0f-a4c1-ae7c3b62e1c6 |
NDC | 68258-8961 |
Product Type | Human Prescription Drug |
Proprietary Name | SEREVENT DISKUS |
Generic Name | Salmeterol Xinafoate |
Dosage Form | Powder, Metered |
Route of Administration | ORAL; RESPIRATORY (INHALATION) |
Marketing Start Date | 1997-11-25 |
Marketing Category | NDA / NDA |
Application Number | NDA020692 |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | SALMETEROL XINAFOATE |
Active Ingredient Strength | 50 ug/1 |
Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1997-11-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020692 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1997-11-25 |
Inactivation Date | 2019-11-13 |
Ingredient | Strength |
---|---|
SALMETEROL XINAFOATE | 50 ug/1 |
SPL SET ID: | c4925b2c-bde1-45fd-8109-dc75bee3b7a3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0173-0520 | SEREVENT | salmeterol xinafoate |
0173-0521 | SEREVENT | salmeterol xinafoate |
68258-8961 | SEREVENT | salmeterol xinafoate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() SEREVENT 73694169 1628891 Live/Registered |
GLAXO GROUP LIMITED 1987-11-09 |